![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 491/052 | (2006.01) |
A61K 31/436 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3820873 |
(13) | Kind of document | T |
(96) | European patent application number | 19745925.8 |
Date of filing the European patent application | 2019-07-11 | |
(97) | Date of publication of the European application | 2021-05-19 |
(45) | Date of publication and mention of the grant of the patent | 2022-11-23 |
(46) | Date of publication of the claims translation | 2023-01-10 |
(86) | Number | PCT/US2019/041334 |
Date | 2019-07-11 |
(87) | Number | WO 2020/014435 |
Date | 2020-01-16 |
(30) | Number | Date | Country code |
201862697100 P | 2018-07-12 | US |
(72) |
BASTIAN, Jolie Anne , US
COHEN, Jeffrey Daniel , US
RUBIO, Almudena , US
SALL, Daniel Jon , US
MCMAHON, Jennifer Anne , US
|
(73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Selektyvūs estrogenų receptorių skaidytojai |
SELECTIVE ESTROGEN RECEPTOR DEGRADERS |
Payment date | Validity (years) | Amount | |
2025-06-19 | 7 | 162.00 EUR |
2026-07-11 |